Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Safer Act
View:
Post by subaru1 on Sep 29, 2023 1:02pm

Safer Act

how many weeks that the Senate will debate on the Safewr act, the way i understand that it could take many months and even a year, what a loosing time. The reschedule of marijuana from schedule 1 to 3 will probably takes many months before the changes happen. In the meantime the stock got a hard time to hold the $0,075, to much sellers again.
Comment by mdjbrown on Sep 29, 2023 1:16pm
better sell s1 as this appears to be keeping you up a nights which isnt healthy for you.    I have a buy order in right now at .075 as I didnt think we would ever see these discounted shares again    The name of the game is patience and it might be a few more months before that pharma snowball starts rolling down the mountain. But once it does, it will be hard to stop! As ...more  
Comment by FredZarfloon on Sep 29, 2023 2:50pm
I would say the name of the game is well timed patience. Previous poster described being patient at $38 and riding it down. A relative of mine was patient with Nortel near the peak much to their loss. Cheers.
Comment by subaru1i on Sep 29, 2023 2:52pm
subaru1...what happens in Brazil does not stay in Brazil.  I was thinking about an hour ago, what if they launch a generic version of Epidiolex in Brazil and their pharma partner their intends to distribute it internationally as well?   I'm only saying this because in 2 conference calls from earlier this year managment made mention of Epidiolex, $900 million USD annual sales and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities